In the present study, we also investigated tumor markers, onconeural antibodies and coexistent anti-thyroid autoantibodies, anti-nuclear/myositis/ganglioside antibody profiles, and anti-MPO/PR3/AchR/AQP4 antibodies. This evidence concerns the gene PRTN3 and neoplasm.